載入...
The cost-effectiveness of biopharmaceuticals: A look at the evidence
Due to the increasing availability and costs of biopharmaceuticals, policymakers are questioning whether they provide good value relative to other health interventions and many are increasingly relying on cost-utility analyses (CUAs) to supplement decision-making. Analyzing data from the Tufts Medic...
Na minha lista:
| Main Authors: | , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Landes Bioscience
2012
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3361664/ https://ncbi.nlm.nih.gov/pubmed/22377753 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/mabs.4.2.18812 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|